Literature DB >> 10849532

Validation of self-reported complications by bone marrow transplantation survivors.

A D Louie1, L L Robison, M Bogue, S Hyde, S J Forman, S Bhatia.   

Abstract

Self-administered questionnaires are commonly used to measure exposures and outcomes in epidemiological research and thus need good validity. With increasing numbers of cancer survivors, there is interest in the ongoing assessment of therapy-related complications. A medical record validation of patient-reported complications following bone marrow transplantation (BMT) was performed using a self-administered questionnaire. The study population consisted of 100 patients who had undergone BMT at the City of Hope. The following self-reported complications were validated using medical records: ocular, endocrine, cardiovascular, musculoskeletal, pulmonary, gastrointestinal, neurological, graft-versus-host disease, and subsequent cancers. Using information from medical records as the standard, sensitivities ranged from 52.9% for subsequent cancers to 100% for avascular necrosis and hypothyroidism. Specificities ranged from 75.4% for ocular complications to 100% for avascular necrosis. There was intermediate to excellent agreement (kappa = 0. 4-1.0) for all complications evaluated. Thus, the agreement between self-reporting and medical records was good for complications with clear diagnostic criteria that are easily communicated to the patient, but was diminished for complications with non-established diagnostic criteria (xerophthalmia) or a fluctuating course (peripheral neuropathies and hypertension). Overall these results suggest that cancer survivors can self-report serious complications with an acceptable level of accuracy in epidemiological research.

Entities:  

Mesh:

Year:  2000        PMID: 10849532     DOI: 10.1038/sj.bmt.1702419

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  44 in total

1.  Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.

Authors:  Nandita Khera; Barry Storer; Mary E D Flowers; Paul A Carpenter; Yoshihiro Inamoto; Brenda M Sandmaier; Paul J Martin; Stephanie J Lee
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

2.  Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Can-Lan Sun; Liton Francisco; Toana Kawashima; Wendy Leisenring; Leslie L Robison; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

3.  Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.

Authors:  Kasey J Leger; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Wendy M Leisenring; Paul J Martin; Jason A Mendoza; Kerryn W Reding; Karen L Syrjala; Stephanie J Lee; Eric J Chow
Journal:  Cancer       Date:  2018-01-09       Impact factor: 6.860

4.  Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Christopher J Fraser; Smita Bhatia; Kirsten Ness; Andrea Carter; Liton Francisco; Mukta Arora; Pablo Parker; Stephen Forman; Daniel Weisdorf; James G Gurney; K Scott Baker
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

5.  The Gynaecologic Leiden Questionnaire: psychometric properties of a self-report questionnaire of sexual function and vaginal changes for gynaecological cancer patients.

Authors:  Q D Pieterse; M M Ter Kuile; C P Maas; G G Kenter
Journal:  Psychooncology       Date:  2008-07       Impact factor: 3.894

6.  Survivors of childhood cancer have increased risk of gastrointestinal complications later in life.

Authors:  Robert Goldsby; Yan Chen; Shannon Raber; Linda Li; Karen Diefenbach; Margarett Shnorhavorian; Nina Kadan-Lottick; Fay Kastrinos; Yutaka Yasui; Marilyn Stovall; Kevin Oeffinger; Charles Sklar; Gregory T Armstrong; Leslie L Robison; Lisa Diller
Journal:  Gastroenterology       Date:  2011-03-17       Impact factor: 22.682

7.  Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.

Authors:  Radhika Gangaraju; Yanjun Chen; Lindsey Hageman; Jessica Wu; Liton Francisco; Michelle Kung; Emily Ness; Mariel Parman; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  Cancer       Date:  2019-08-30       Impact factor: 6.860

8.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

9.  Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.

Authors:  Can-Lan Sun; John H Kersey; Liton Francisco; Saro H Armenian; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2013-04-10       Impact factor: 5.742

10.  Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.

Authors:  F Lennie Wong; Liton Francisco; Kayo Togawa; Alysia Bosworth; Mitzi Gonzales; Cara Hanby; Melanie Sabado; Marcia Grant; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.